ArticleCancers2023

Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating

Petros Christopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.